Annual Operating Expenses
$68.51 M
+$7.35 M+12.02%
December 31, 2023
Summary
- As of February 8, 2025, LXEO annual total operating expenses is $68.51 million, with the most recent change of +$7.35 million (+12.02%) on December 31, 2023.
- During the last 3 years, LXEO annual operating expenses has risen by +$63.41 million (+1241.73%).
- LXEO annual operating expenses is now at all-time high.
Performance
LXEO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$31.54 M
+$7.99 M+33.94%
September 30, 2024
Summary
- As of February 8, 2025, LXEO quarterly total operating expenses is $31.54 million, with the most recent change of +$7.99 million (+33.94%) on September 30, 2024.
- Over the past year, LXEO quarterly operating expenses has increased by +$11.27 million (+55.59%).
- LXEO quarterly operating expenses is now at all-time high.
Performance
LXEO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
LXEO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +12.0% | +55.6% |
| 3 y3 years | +1241.7% | +55.6% |
| 5 y5 years | +1241.7% | +55.6% |
LXEO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +31.0% | at high | +125.7% |
| 5 y | 5-year | at high | +1241.7% | at high | +125.7% |
| alltime | all time | at high | +1241.7% | at high | +125.7% |
Lexeo Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $31.54 M(+33.9%) |
| Jun 2024 | - | $23.55 M(+1.1%) |
| Mar 2024 | - | $23.29 M(+55.5%) |
| Dec 2023 | $68.51 M | $14.97 M(-26.1%) |
| Sep 2023 | - | $20.27 M(+45.1%) |
| Jun 2023 | - | $13.97 M(-27.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2023 | - | $19.29 M(+26.9%) |
| Dec 2022 | $61.16 M(+17.0%) | $15.20 M(-15.6%) |
| Sep 2022 | - | $18.01 M(+17.4%) |
| Jun 2022 | - | $15.35 M |
| Dec 2021 | $52.29 M(+924.1%) | - |
| Dec 2020 | $5.11 M | - |
FAQ
- What is Lexeo Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Lexeo Therapeutics?
- What is Lexeo Therapeutics annual operating expenses year-on-year change?
- What is Lexeo Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Lexeo Therapeutics?
- What is Lexeo Therapeutics quarterly operating expenses year-on-year change?
What is Lexeo Therapeutics annual total operating expenses?
The current annual operating expenses of LXEO is $68.51 M
What is the all time high annual operating expenses for Lexeo Therapeutics?
Lexeo Therapeutics all-time high annual total operating expenses is $68.51 M
What is Lexeo Therapeutics annual operating expenses year-on-year change?
Over the past year, LXEO annual total operating expenses has changed by +$7.35 M (+12.02%)
What is Lexeo Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of LXEO is $31.54 M
What is the all time high quarterly operating expenses for Lexeo Therapeutics?
Lexeo Therapeutics all-time high quarterly total operating expenses is $31.54 M
What is Lexeo Therapeutics quarterly operating expenses year-on-year change?
Over the past year, LXEO quarterly total operating expenses has changed by +$11.27 M (+55.59%)